Moreover, the therapeutic potential of ECS modulation—such as FAAH inhibitors to boost AEA/OEA/PEA or CB1 agonists to normalize 2-AG—warrants exploration, given anecdotal reports of cannabinoid benefits in ADHD symptom management (47). Here, FAAH is linked to attention deficit-hyperactivity disorder.